Drug Database
Back to search

Poland· PL-100449234

Gliptivil

A metformin und sulfonylharnstoffe product containing vildagliptinum, registered in Poland by Aurovitas Pharma Polska Sp. z o.o.. The same ATC class is registered in 4 of our 19 countries.

ATC A10BD02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedGliptivilATCA10BD02REGISTER NO.PL-100449234PACKS LISTED5CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about vildagliptinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Metformin und sulfonylharnstoffe is registered in 4 of 19 countries.

Countries holding a registration under ATC A10BD02 (metformin und sulfonylharnstoffe), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 4 of them publish a price we can compare per daily dose
Search metformin und sulfonylharnstoffe products by name

Metformin und sulfonylharnstoffe · ATC A10BD02

4 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Italyprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Vildagliptinum
Manufacturer
Aurovitas Pharma Polska Sp. z o.o.
Country
Poland (PL)
ATC code
A10BD02
ATC class
Metformin und Sulfonylharnstoffe
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 5

  • gtin
    05909991492724
  • gtin
    05909991492731
  • gtin
    05909991492748
  • gtin
    05909991492755
  • gtin
    05909991492762

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for metformin und sulfonylharnstoffe.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check metformin und sulfonylharnstoffe against other medicinesHow interaction checks work

Metformin und sulfonylharnstoffe · interactions on record

3 records

3 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Metformin und sulfonylharnstoffe in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All metformin und sulfonylharnstoffe products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Melkart, Saxotin
  • Belgium · Vildagliptin Krka
  • Bulgaria · Глипвило, Далмевин
  • Cyprus · Aglimon, Dalmevin
  • Czechia · Alikval, Anvildis
  • Germany · Vildabetes, Vildagliptin Al
  • Denmark · Vildagliptin "a. E. Tiefenbacher", Vildagliptin "axunio"
  • Estonia · Dalmevin, Glypvilo
  • Spain · Vildagliptina, Vildagliptina Alter
  • Finland · Vildagliptin Krka, Vildagliptin Ratiopharm
  • France · Vildagliptine Accord, Vildagliptine Arrow
  • United Kingdom (Northern Ireland) · Vildagliptin, Vildagliptin Accord-Uk
  • Greece · Dalmevin, Varbos
  • Croatia · Agnis, Dalmevin
  • Hungary · Agartha, Alikval
  • Ireland · Vildagliptin Krka
  • Iceland · Galvus, Jalra
  • Italy · Vildagliptin Accord, Vildagliptin Aurobindo
  • Liechtenstein · Galvus, Jalra
  • Lithuania · Dalmevin, Glypvilo
  • Latvia · Dalmevin, Glypvilo
  • Malta · Alikval, Dalmevin
  • Netherlands · Vilanov, Vildagliptine Accord
  • Norway · Galvus, Jalra
  • Portugal · Tutecvi, Vezagla
  • Romania · Agartha, Dalmevin
  • Sweden · Dalmevin, Kwikaton
  • Slovenia · Glypvilo
  • Slovakia · Anvildis, Dalmevin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c0b1b9ca-9604-469d-9eaf-ff15299deeea
GET /v1/drugs/c0b1b9ca-9604-469d-9eaf-ff15299deeea?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "50 mg",
  "packaging": "05909991492724 ¦ Rp ¦ 146278\n28 tabl.\n05909991492731 ¦ Rp ¦ 146279\n56 tabl.\n05909991492748 ¦ Rp ¦ 146280\n60 tabl.\n05909991492755 ¦ Rp ¦ 146281\n30 tabl.\n05909991492762 ¦ Rp ¦ 146282\n14 tabl.",
  "substance": "Vildagliptinum 50 mg",
  "common_name": "Vildagliptinum",
  "pl_product_id": "100449234",
  "pozwolenie_nr": "27231",
  "auth_procedure": "DCP",
  "authorisation_validity": "2027-07-29"
}
API referenceMCP serverPlans

See everything about metformin und sulfonylharnstoffe.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console